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Background: Infection with Mycobacterium ulcerans (MU) causes extensive destruction of tis-
sues with the formation of large ulcers on exposed parts of the body. Healing leads to
extensive scarring and other complications which may impair function.
ObjectiveTo document the complications of MU disease and the reconstructive surgery per-
formed to correct them.
Study design: Prospective from January 2010 to December 2012.
Setting: Ahafo Ano, Amansie West, Asunafo, and Upper Denkyira districts of Ghana.
Methods: Patients with unhealed lesions after completing 8 weeks of rifampicin and strep-
tomycin treatment, and patients with complications of MU disease were selected and pre-
pared for surgical treatment.
Results: 61 patients were treated successfully with rifampicin and streptomycin without
complications. 65 patients presented with complications; they comprised 34 males and
31 females. Their ages ranged from 1 year 3 months to 80 years with mean age of 29.7
(S.D. 20.1).The types of lesions seen were ulcers (54), contractures (7), chronic osteomyelitis
(one), subluxation of knee joint (one), salivary gland fistula (one) and Marjolin’s ulcer (one).
The lesions were distributed as follows: 69.2% on the lower, and 23.1% on the upper limbs,
6.2% on the head and neck and 1.5% on the trunk. Wound excision with or without skin
grafting was done in 84.6% of patients, surgery for contractures in10.8%, and sequestrec-
tomy, exploration and ligation of fistula, groin dissection and above knee amputation in
4.6%.
ConclusionWhilst ulcers, the commonest MU lesions, are being controlled with antibiotics,
rare complications of the disease are also emerging.
 2013 Asian-African Society for Mycobacteriology. Published by Elsevier Ltd. All rights
reserved.Introduction cytotoxic and immunosuppressive properties [3]. InfectionThe mycolactone toxin produced by Mycobacterium ulcerans
(MU) is mainly responsible for the pathology of Buruli ulcer
disease [1]. This toxin is produced when the organism is
infected with a transmissible plasmid [2]. The toxin has-African Society for Myco
f Medical Sciences, Kom
om.with MU leads to extensive destruction of the tissues with
the formation of large ulcers especially on exposed parts of
the body such as the limbs, head, and neck [4]. Healing of
MU lesions may occur spontaneously by secondary intention
after sloughing of the epidermis and subcutaneous fat withbacteriology. Published by Elsevier Ltd. All rights reserved.
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Fig. 1 – Age distribution of 65 patients with complications of
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this mode of healing. Lesions are usually on the extremities of
children. Scarring often leads to contractures, subluxation of
joints, disuse atrophy, and distal lymphedema [5].
Treatment of MU disease with antibiotics, namely rifampi-
cin and streptomycin, in accordance withWHO recommenda-
tions [6] led to a reduction in the number of early active
lesions in some series [7]. Even for those requiring surgery
after antibiotic treatment, the extent of surgery was also re-
duced, with most patients requiring only simple skin grafting
[8]. However, for patients presenting with extensive ulcers for
the first time, recurrent ulcers, or complications of the dis-
ease, the management tends to involve complicated recon-
structive surgical procedures to improve form and function.
The objective of the study was to document the complica-
tions of MU disease, including those occurring after antibiotic
treatment, and to determine the type of reconstructive sur-
gery that was required to correct them.
Patients and methods
A three-year prospective study was undertaken in four Buruli
ulcer endemic districts located in the middle belt of Ghana.
The communities were Tepa in Ahafo Ano (in 2010), Agroye-
sum in Amansie West (in 2011), Kukuom in Asunafo (in
2012), and Dunkwa in Upper Denkyira (in 2012) districts.
Patients with lesions suspected to be MU disease were
identified by specially trained health workers in the commu-
nities, and referred to the district hospitals for confirmation
of the diagnosis by the doctor, either by direct smear exami-
nation, polymerase chain reaction (PCR), or by histopathology
of tissue obtained by punch biopsy, or by excision. PCR and
histopathology were either done at the Kumasi Centre for Col-
laborative Research (KCCR) into Tropical Diseases or Komfo
Anokye Teaching Hospital (KATH) in Kumasi. Culture and
sensitivity for MU was not done routinely for confirmation
of MU disease during the current study. All the patients with
active disease were treated with rifampicin at 10 mg/kg body
weight orally daily for 8 weeks and streptomycin 15 mg/kg
body weight by intramuscular injection daily for 8 weeks in
accordance with WHO recommendations.
Patients whose lesions were not completely healed after
8 weeks of antibiotic treatment, and patients who had devel-
oped complications, or were presenting with complications at
the time of first clinical diagnosis were selected for surgical
treatment. Surgery involved wound debridement, wound
excision with or without skin grafting, release and repair of
contractures, and sequestrectomy, depending on the type of
MU lesions. The surgeries were performed at the district hos-
pitals by a team comprising one plastic surgeon and one the-
atre nurse from Komfo Anokye Teaching Hospital, who were
assisted by a doctor, an anesthetist and theatre nurses from
the district hospitals.
Surgery was also performed for four patients who pre-
sented with four uncommon complications of MU disease:
(1) A 19-year-old girl presented with a recurrent Buruli
ulcer involving the right knee. She has had two previ-
ous wound excisions and split thickness skin graftingdone, but they failed on both occasions. She presented
with a granulating ulcer on her right knee joint, about
10 cm by 6 cm on the anterior aspect. Wound excision
and split thickness skin grafting was done. The limb
was splintered in an above-knee plaster of paris (POP)
back-slab for 2 weeks before weight bearing was
allowed, and walking started.
(2) A 14-year-old girl presented with chronic osteomyelitis
of the right humerus, following Buruli ulcer of the right
arm for 3 years. Sequestrectomy was performed for her.
(3) A 14-year-old boy with a healed Buruli ulcer of the left
cheek presented with a fistula in the scar discharging
copious amount of saliva, which soaked his clothes
continuously. The fistula was explored, cannulated
and ligated under general anesthesia.
(4) A 19-year-old boy who had had a Buruli ulcer for
10 years, presented with a malignant ulcer of the distal
third of the right thigh and right knee. He also had a
pathological fracture of the right tibia. In addition, he
had palpably enlarged right inguinal lymph nodes. He
underwent a block dissection of the right inguinal
lymph nodes, and an above-knee amputation of the
right lower limb. Histological examination of the
resected tissue confirmed squamous cell carcinoma.
The case notes of all the patients who were treated by the
author during the study period were compiled and analyzed.
Results
The study period extended from January 2010 to December
2012. A total of 126 patients were treated for MU disease. In
61 patients, the wounds healed completely with the antibiot-
ics rifampicin and streptomycin without complications. They
did not require any surgery, and were hence excluded from
the study.
65 patients presented with complications of MU disease,
and were entered into the study. They comprised 10 patients
from Tepa, 9 from Agroyesum, 33 from Kukuom, and 13 from
Dunkwa. They comprised 34 men and 31 females, giving a
male to female ratio of 1.1:1. Their ages ranged from 1 year
3 months to 80 years, with a mean age of 29.7 (SD 20.1). The
age distribution of the patients is shown in Fig. 1.Mycobacterium ulcerans disease.
Table 1 – Distribution of Mycobacterium ulcerans lesions on
various parts of the body.
Site Frequency (percentage)
Head and neck 4 (6.2%)
Scalp 1
Temple 1
Cheek 2
Upper limb 15 (23.1%)
Shoulder 1
Arm 2
Elbow 4
Forearm 3
Wrist 4
Hand 1
Trunk 1 (1.5%)
Chest wall 1
Lower limb 45 (69.2%)
Thigh 1
Knee 7
Leg 26
Ankle 4
Foot 7
Fig. 2 – Salivary gland fistula of the left cheek following MU
disease.
Fig. 3 – Marjolin’s ulcer of right knee with pathological
fracture of the right tibia as complications of MU disease.
Fig. 4a – Contracture of right wrist from MU disease (pre-
operative).
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is shown in Table 1. About 92% of the lesions were on the
limbs, with the lower limbs comprising about 69% of the le-
sions. This distribution of the lesions confirms the prevalence
of MU lesions on exposed parts of the body, especially on the
limbs, seen in some series [9].
The types of MU lesions seen were ulcers (54, 83.1%), con-
tractures (7, 10.8%), and 4 (6.1%) other uncommon complica-
tions: subluxation of the knee joint, chronic osteomyelitis of
the humerus, salivary (parotid) gland fistula (Fig. 2), and Marj-
olin’s ulcer from a recurrent Buruli ulcer (Fig. 3).
The sizes of the ulcers were: 5 cm or less (category 1, 9 pa-
tients); 5–15 cm (category 2, 34 patients); more than 15 cm
(category 3, 11 patients).
There were four patients who presented with contractures
of the wrist; three involved the hand and wrist; one involved
only the wrist. The deformity caused by the hand and wrist
contractures were dorsiflexion in two cases and volar flexion
in two cases (Figs. 4a and 4b). A knee contracture caused a
fixed-flexion deformity of about 80.
The types of surgical procedures that were performed for
the 65 patients who presented with complications are shown
in Table 2. Since ulcers were the commonest lesions seen, the
commonest procedures were wound excision and skin
grafting.
Discussion
The efficacy of antibiotic treatment, namely rifampicin and
streptomycin, for MU disease has been demonstrated in sev-
eral series [10–12]. Initially it was demonstrated to be effective
only in small (less than 10 cm diameter) and early (less than
six months old) lesions. Recently, it has been found that all
forms of MU disease – plaques, nodules, edema and ulcers –
however extensive, respond well to antibiotic treatment [12].However, not only antibiotics promote healing of MU
lesions; spontaneous healing of MU lesions, without any form
of treatment, has been known to occur [5]. The scar tissue
resulting from this slow, normal healing process causes
Fig. 4b – Right wrist after release of contracture and groin
flap repair.
Fig. 5 – MU disease of right arm treated with herbs.
Table 2 – Surgical procedures performed for 65 patients with
complications of Mycobacterium ulcerans disease.
Surgical procedure Frequency (%)
Excision and skin grafting 43 (66.2)
Excision 5 (7.7)
Skin grafting 4 (6.2)
Release of contracture and groin flap repair 4 (6.2)
Release of contracture and skin grafting 3 (4.6)
Re-grafting 3 (4.6)
Sequestrectomy 1 (1.5)
Exploration and ligation of salivary
(parotid) fistula
1 (1.5)
Right groin dissection and above
knee amputation
1 (1.5)
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movement. Thick or tight scars resist injuries poorly, may
limit movement, distort appearance and prevent function.
Herbal medicines used in some endemic communities by lo-
cal people to treat MU disease also lead to this kind of healing.
In the latter two situations, and also sometimes with antibi-
otic treatment unsupported by physiotherapy, healing leads
to contracture formation which seriously impairs function
(Fig. 5). In the current study, 10.8% of the surgical procedures
were performed for the release and repair of contractures,
second only to surgery for ulcers.
Scars from MU disease are usually dry and may crack or
ulcerate during play or work. Such unstable scars may, over
many years, develop into squamous cell carcinoma–Marjo-
lin’s ulcer [13]. Even though only a single such case was
encountered in the current study, it is significant in terms of
the magnitude of surgery performed and the resulting loss
of limb.
These difficult complications of MU disease usually re-
quire complex reconstructive surgery and physiotherapy to
correct. Such services are usually not available at the district
hospitals in the endemic communities, and patients have to
be transferred to a tertiary centre (KATH).The usefulness of antibiotic treatment is limited by
patients who report late with advanced disease. Early lesions
of MU disease are usually painless [5] and do not usually
prevent patients from performing their activities of daily liv-
ing. They are, therefore, likely to be ignored by the patient un-
til they become bigger, or painful from secondary bacterial
infection [5]. Patients presenting the first time with severe
contractures or malignant complications may not have the
MU organisms in the tissues to be treated with antibiotics.
Surgical management in such cases is the only option. For
antibiotic treatment to be more effective in achieving a cure
for MU disease, and also to reduce the need for extensive sur-
gery, early case detection for MU lesions should be empha-
sized in all endemic communities.
Conclusion
Whilst ulcers, the commonest MU lesions, are being con-
trolled with rifampicin and streptomycin, rare complications
of the disease which require skillful reconstructive surgery
and physiotherapy to correct are also emerging.
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